...
首页> 外文期刊>Nature Communications >Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies
【24h】

Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies

机译:转录组合协会研究中具有概率孟德尔随机性的水平肺炎的测试和控制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Integrating results from genome-wide association studies (GWASs) and gene expression studies through transcriptome-wide association study (TWAS) has the potential to shed light on the causal molecular mechanisms underlying disease etiology. Here, we present a probabilistic Mendelian randomization (MR) method, PMR-Egger, for TWAS applications. PMR-Egger relies on a MR likelihood framework that unifies many existing TWAS and MR methods, accommodates multiple correlated instruments, tests the causal effect of gene on trait in the presence of horizontal pleiotropy, and is scalable to hundreds of thousands of individuals. In simulations, PMR-Egger provides calibrated type I error control for causal effect testing in the presence of horizontal pleiotropic effects, is reasonably robust under various types of model misspecifications, is more powerful than existing TWAS/MR approaches, and can directly test for horizontal pleiotropy. We illustrate the benefits of PMR-Egger in applications to 39 diseases and complex traits obtained from three GWASs including the UK Biobank.
机译:通过转录组 - 范围的协会研究(TWA)将来自基因组关联研究(GWASS)和基因表达研究的结果集成了疾病病因的因果分子机制潜力。在这里,我们提出了一个概率孟德尔随机化(MR)方法,PMR-Egger,用于TWA应用程序。 PMR-Egger依赖于统一许多现有TWA和MR方法的先生似然框架,适应多种相关仪器,在水平胸膜内的存在下测试基因对特性的因果效应,并且可扩展到数十万个体。在仿真中,PMR-Egger为校准类型I错误控制提供了在存在水平渗透效果中的因果效应测试,在各种类型的模型误操作下具有合理强大,比现有的TWA / MR方法更强大,可以直接测试水平pleiotropy。我们说明了PMR-Egger在应用到39种疾病和三种GWAS中获得的复杂性状的益处,包括英国Biobank。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号